Lyla El-Fayomi
Dr. Lyla El-Fayomi has a PhD in Molecular Genetics from the University of Toronto. She is a researcher and freelance science writer headquartered in the Greater Toronto Area. Follow her on X @DrLylaElFay
Posts by: Lyla
Optogenetic tools have officially changed the fight against blindness
Patients diagnosed with degenerative eye disorders, such as retinitis pigmentosa (RP) or choroideremia, face a gradual loss of light-sensing cells that eventually leads to blindness. Historically, most treatments could only aim to slow disease progression; however, bioengineering is changing toolkits, allowing scientists and doctors to do more. Optogenetics is an excellent example of this, and […]
Regenerative Medicine News Under the Microscope – Spring Edition
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on Parkinson’s cell therapy awaits you. Let’s jump in! Pick of the Season Optogenetics […]
All eyes on Japan: Allogeneic iPSC therapy for limbic stem cell deficiency
A brief recap You might recall Johanne Provost’s story, which I covered in the September edition of RMNU🔬. New details have since emerged regarding the specifics of her disease: Ms. Provost had been suffering from a rare autoimmune disease – lichen planus – that destroyed the limbal stem cells maintaining the transparent layer of tissue […]
Regenerative Medicine News Under the Microscope – Summer Edition, Part I
The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half. Pick of the Summer (so far) The first custom CRISPR […]